More Articles

Patients and Medical

Barcelona 2019: Patient Initiative Finalists Revealed

Adam Chapman, (Jan 27, 2019)

We have whittled it down to the final five. Here are the contenders for the Most Valuable Patient Initiative award
Access and Evidence

Embracing Early Access

Katie Osborne, (Jan 22, 2019)

Compassionate use programs offer hope to patients who have ran out of options. But the benefits must be weighed against the risks.

It’s Like You Were Virtually There

Lucy Fulford, (Jan 9, 2019)

Digital innovations are transforming HCP interactions in more ways than one.

Reclaim The Glory Of Value

Adam Chapman, (Jan 8, 2019)

Value has become a buzzword, but its importance cannot be overstated. How do we ensure its survival?
Access and Evidence

RWE: The Missing Link

Nicola Davies, (Jan 7, 2019)

Linking real-world datasets is essential to deliver true insights
Patients and Medical

Up Close And Personal

Lucy Fulford, (Jan 7, 2019)

Ian Talmage’s experience as a patient and carer has left an indelible mark on his life and his career.

What Can Pharma Expect in 2019?

The eyeforpharm..., (Jan 7, 2019)

Our look at the biggest trends hitting the industry over the coming 12 months
Access and Evidence

Gold Standard: Standardizing RWD

Nicola Davies, (Jan 4, 2019)

If real-world data is to deliver on its promise, it needs to be standardized

Releasing Pharma’s Potential

Adam Chapman, (Jan 3, 2019)

The industry has a new frontier in its sights. LEO Pharma’s CEO provides us with a blueprint to get there.

Commercialising Data: The Great Conundrum

Ross Davies, (Jan 1, 2019)

Big data might be everywhere, but its commercial use across pharma is still wanting. Sales and advanced analytics shouldn’t be mutually exclusive